A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT05039931 · WITHDRAWN
Trial details
- NCT number
- NCT05039931
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-15
- Primary completion
- 2023-06-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.